Article info
PDFAdverse drug reactions
Post BNT162b2 mRNA COVID-19 vaccination Henoch-Schӧnlein Pupura
- Correspondence to Dr Samuel Sherng Young Wang, National Centre for Infectious Diseases, Singapore; samuel.wang{at}mohh.com.sg
Citation
Post BNT162b2 mRNA COVID-19 vaccination Henoch-Schӧnlein Pupura
Publication history
- Received November 23, 2021
- Accepted December 18, 2021
- First published January 12, 2022.
Online issue publication
November 22, 2022
Article Versions
- Previous version (12 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.